High-dose reirradiation of in-field recurrence lung cancer in the THOrax (RETHO): toxicity analysis of a prospective trial
International Journal of Radiation Oncology*Biology*Physics · 2026-11
DOI: 10.1016/j.ijrobp.2026.10.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-11. Verfasst von Dr M Duijm und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Department of Radiation Oncology, Leiden University Medica…. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
INTRODUCTION: This prospective phase II XXX trial evaluated high-dose thoracic reirradiation for in-field recurrent lung cancer while respecting the cumulative dose to the organs at risk. Here, we report the toxicity and dosimetric results of the XXX trial. METHODS: Patients with recurrent lung cancer within 5cm of the previously irradiated high-dose region (50Gy10 EQD2) were eligible. Patients were treated in a radical setting (≥45Gy10 EQD2) using conventionally (chemo)radiotherapy or stereotactic radiotherapy. Cumulative dose constraints were: tracheobronchial tree Dmax 110Gy3 EQD2, esophagus Dmax 100Gy3 EQD2 and spinal cord Dmax 75Gy3 EQD2. All doses were converted to EQD2 using α/β values of 10Gy (Gy10) for the tumor or acute effects and 3Gy for late effects (Gy3). RESULTS: Sixty patients were included. Thirty-eight patients were reirradiated with conventionally (chemo)radiotherapy most commonly 50Gy in 25 fractions or 60Gy in 30 fractions, while 22 patients received stereotactic radiotherapy most commonly 52.5Gy in 7 fractions. After a median follow-up of 26 months, no grade 4-5 toxicity was reported. Ten patients (17%) experienced grade 3 toxicity, including 7 cases of radiation pneumonitis. Dosimetric data were available for 59 patients. Median prescribed reirradiation dose was 60Gy10 EQD2, resulting in a median cumulative PTV Dmax of 130Gy10 EQD2. The cumulative esophagus dose exceeded 80Gy3 in 20 patients, cumulative trachea dose exceeded 80 Gy3 in 26 patients and cumulative bronchus dose exceeded 100Gy3 in 26 patients. Both cumulative lung V20 and cumulative mean lung dose were significantly associated with grade 2-3 radiation pneumonitis (p-value
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Department of Radiation Oncology, Leiden University Medical Centre, Leiden, the Netherlands. Electronic address: m.duijm@lumc.nl.
- Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
- Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
- Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
- Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Electronic address: e.vanwerkhoven@erasmusmc.nl.
- Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Zitieren
APA
Duijm, D. M., Cammareri, E., Granton, D. P. V., Schillemans, W., Petit, D. S., Belderbos, D. J., van Werkhoven, D. E., Cornelissen, D. R., Knegjens, J. L., & Nuyttens, D. J. J. (2026). High-dose reirradiation of in-field recurrence lung cancer in the THOrax (RETHO): toxicity analysis of a prospective trial. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2026.10.021
Vancouver
Duijm DM, Cammareri E, Granton DPV, Schillemans W, Petit DS, Belderbos DJ, et al. High-dose reirradiation of in-field recurrence lung cancer in the THOrax (RETHO): toxicity analysis of a prospective trial. International Journal of Radiation Oncology*Biology*Physics. 2026. doi:10.1016/j.ijrobp.2026.10.021
BibTeX
@article{Duijm2026,
author = {Duijm, Dr M and Cammareri, E and Granton, Dr P V and Schillemans, W and Petit, Dr S and Belderbos, Dr J and van Werkhoven, Dr E and Cornelissen, Dr R and Knegjens, J L and Nuyttens, Dr J J},
title = {High-dose reirradiation of in-field recurrence lung cancer in the THOrax (RETHO): toxicity analysis of a prospective trial},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
doi = {10.1016/j.ijrobp.2026.10.021}
}
EUVIMED